Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$36.71 - $44.15 $178,667 - $214,878
4,867 Added 2.79%
179,271 $7.46 Million
Q1 2023

May 12, 2023

BUY
$36.81 - $48.12 $181,289 - $236,991
4,925 Added 2.91%
174,404 $7.2 Million
Q4 2022

Feb 13, 2023

SELL
$35.68 - $44.71 $15,877 - $19,895
-445 Reduced 0.26%
169,479 $6.99 Million
Q3 2022

Nov 10, 2022

SELL
$42.51 - $54.02 $22,360 - $28,414
-526 Reduced 0.31%
169,924 $7.44 Million
Q2 2022

Aug 12, 2022

SELL
$46.84 - $59.75 $95,272 - $121,531
-2,034 Reduced 1.18%
170,450 $8.38 Million
Q1 2022

May 18, 2022

SELL
$48.09 - $57.79 $1,635 - $1,964
-34 Reduced 0.02%
172,484 $9.78 Million
Q1 2022

May 13, 2022

BUY
$48.09 - $57.79 $25,006 - $30,050
520 Added 0.3%
172,518 $9.78 Million
Q4 2021

Feb 11, 2022

BUY
$47.19 - $62.68 $32,797 - $43,562
695 Added 0.41%
171,998 $9.03 Million
Q3 2021

Nov 12, 2021

SELL
$56.91 - $67.81 $62,145 - $74,048
-1,092 Reduced 0.63%
171,303 $10.3 Million
Q2 2021

Aug 13, 2021

SELL
$64.02 - $71.72 $24,839 - $27,827
-388 Reduced 0.22%
172,395 $11.7 Million
Q1 2021

May 14, 2021

BUY
$53.26 - $68.08 $73,285 - $93,678
1,376 Added 0.8%
172,783 $11.3 Million
Q4 2020

Feb 05, 2021

BUY
$43.41 - $56.51 $433,535 - $564,365
9,987 Added 6.19%
171,407 $9.66 Million
Q3 2020

Nov 06, 2020

BUY
$47.43 - $60.75 $9,438 - $12,089
199 Added 0.12%
161,420 $7.84 Million
Q2 2020

Aug 13, 2020

BUY
$43.51 - $66.59 $130,399 - $199,570
2,997 Added 1.89%
161,221 $8.97 Million
Q1 2020

May 14, 2020

BUY
$32.82 - $81.13 $3,282 - $8,113
100 Added 0.06%
158,224 $8.02 Million
Q4 2019

Feb 14, 2020

SELL
$60.96 - $77.7 $430,682 - $548,950
-7,065 Reduced 4.28%
158,124 $12.2 Million
Q3 2019

Nov 01, 2019

BUY
$55.78 - $68.08 $79,263 - $96,741
1,421 Added 0.87%
165,189 $10.5 Million
Q2 2019

Aug 02, 2019

BUY
$53.69 - $65.47 $40,589 - $49,495
756 Added 0.46%
163,768 $9.59 Million
Q1 2019

May 02, 2019

BUY
$44.53 - $58.9 $140,937 - $186,418
3,165 Added 1.98%
163,012 $9.26 Million
Q4 2018

Jan 30, 2019

BUY
$47.64 - $71.26 $8,241 - $12,327
173 Added 0.11%
159,847 $7.92 Million
Q3 2018

Nov 02, 2018

SELL
$52.03 - $71.41 $1.13 Million - $1.54 Million
-21,629 Reduced 11.93%
159,674 $11.3 Million
Q2 2018

Aug 10, 2018

SELL
$48.15 - $56.68 $19,500 - $22,955
-405 Reduced 0.22%
181,303 $9.45 Million
Q1 2018

May 09, 2018

BUY
$46.03 - $61.28 $234,753 - $312,528
5,100 Added 2.89%
181,708 $9.49 Million
Q4 2017

Feb 02, 2018

SELL
$50.58 - $60.79 $111,276 - $133,738
-2,200 Reduced 1.23%
176,608 $10.3 Million
Q3 2017

Nov 01, 2017

BUY
$53.54 - $68.0 $9.57 Million - $12.2 Million
178,808
178,808 $9.92 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track Mario Gabelli's Portfolio

Track Mario Gabelli Portfolio

Follow Mario Gabelli (Gamco Investors, Inc. Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.